Palo Alto Investors LP Long-Term Concentrated

Location: Palo Alto, CA

CIK: 0001306923 · Show all filings

Period: Q4 2017 (← Previous) (Next →)

Filing Date: Feb 14, 2018

Total Value: $2.322B (100.0% shares, 0.0% debt)

Holdings (37)

ABIOMED INC 12.8%
Value $297M Shares 1,585,413 Est. Cost $32.04 Unrealized
UTHR UNITED THERAPEUTICS CORP DEL 10.2%
Value $238M Shares 1,606,250 Est. Cost $88.34 Unrealized +43.9%
CLOVIS ONCOLOGY INC 10.0%
Value $231M Shares 3,402,781 Est. Cost $54.40 Unrealized
BMRN BIOMARIN PHARMACEUTICAL INC 9.6%
Value $223M Shares 2,497,806 Est. Cost $79.67 Unrealized +9.1%
INSM INSMED INC 8.6%
Value $200M Shares 6,404,586 Est. Cost $15.54 Unrealized +90.1%
ALEXION PHARMACEUTICALS INC 5.8%
Value $134M Shares 1,117,642 Est. Cost $121.07 Unrealized
SAGE THERAPEUTICS INC 5.8%
Value $134M Shares 810,806 Est. Cost $46.14 Unrealized
FOLD AMICUS THERAPEUTICS INC 3.7%
Value $86.43M Shares 6,006,022 Est. Cost $6.23 Unrealized +120.4%
EPIZYME INC 3.7%
Value $86.1M Shares 6,860,843 Est. Cost $15.12 Unrealized
IMMUNOMEDICS INC 3.3%
Value $77.15M Shares 4,774,261 Est. Cost $11.54 Unrealized
VNDA VANDA PHARMACEUTICALS INC 2.7%
Value $63.17M Shares 4,155,670 Est. Cost $8.70 Unrealized +70.5%
WRIGHT MED GROUP N V 2.6%
Value $60.75M Shares 2,736,293 Est. Cost $23.42 Unrealized
STAA STAAR SURGICAL CO 2.3%
Value $54.2M Shares 3,496,752 Est. Cost $8.00 Unrealized +85.7%
ACAD ACADIA PHARMACEUTICALS INC 2.1%
Value $49.41M Shares 1,641,030 Est. Cost $29.82 Unrealized +7.2%
ALGN ALIGN TECHNOLOGY INC 2.0%
Value $47.22M Shares 212,507 Est. Cost $94.04 Unrealized +141.5%
AMAG PHARMACEUTICALS INC 2.0%
Value $46.28M Shares 3,493,220 Est. Cost $29.37 Unrealized
AIMMUNE THERAPEUTICS INC 1.9%
Value $43.36M Shares 1,146,419 Est. Cost $22.25 Unrealized
PRTA PROTHENA CORP PLC 1.8%
Value $41.08M Shares 1,095,655 Est. Cost $32.98 Unrealized +54.4%
KARYOPHARM THERAPEUTICS INC 1.5%
Value $34.03M Shares 3,544,439 Est. Cost $19.57 Unrealized
CELGENE CORP 1.4%
Value $32.14M Shares 307,940 Est. Cost $97.79 Unrealized
MOMENTA PHARMACEUTICALS INC 1.1%
Value $25.41M Shares 1,821,576 Est. Cost $14.12 Unrealized
ALDER BIOPHARMACEUTICALS INC 0.9%
Value $21.07M Shares 1,840,246 Est. Cost $11.48 Unrealized
SHIRE PLC 0.9%
Value $21.07M Shares 135,800 Est. Cost $216.61 Unrealized
EXAS EXACT SCIENCES CORP 0.7%
Value $16.33M Shares 310,876 Est. Cost $13.61 Unrealized +292.2%
RIGEL PHARMACEUTICALS INC 0.7%
Value $15.27M Shares 3,935,584 Est. Cost $3.40 Unrealized
BIOVERATIV INC 0.6%
Value $14.26M Shares 264,400 Est. Cost $56.44 Unrealized
GILD GILEAD SCIENCES INC 0.5%
Value $12.6M Shares 175,900 Est. Cost $62.02 Unrealized -9.9%
DICERNA PHARMACEUTICALS INC 0.2%
Value $4.523M Shares 500,913 Est. Cost $5.39 Unrealized
SUNESIS PHARMACEUTICALS INC 0.2%
Value $4.29M Shares 1,162,473 Est. Cost $4.37 Unrealized
ALIMERA SCIENCES INC 0.2%
Value $4.008M Shares 3,013,793 Est. Cost $4.88 Unrealized
IDERA PHARMACEUTICALS INC 0.1%
Value $1.301M Shares 616,355 Est. Cost $3.70 Unrealized
ZOGENIX INC 0.1%
Value $1.181M Shares 29,500 Est. Cost $13.36 Unrealized
CYTK CYTOKINETICS INC 0.0%
Value $1.008M Shares 123,686 Est. Cost $6.71 Unrealized +69.1%
MELINTA THERAPEUTICS INC 0.0%
Value $801K Shares 50,689 Est. Cost $15.80 Unrealized
HISTOGENICS CORP 0.0%
Value $621K Shares 302,922 Est. Cost $11.00 Unrealized
SOPHIRIS BIO INC 0.0%
Value $561K Shares 247,000 Est. Cost $2.60 Unrealized
TREVENA INC 0.0%
Value $546K Shares 341,300 Est. Cost $2.30 Unrealized